Literature DB >> 16333533

Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device.

B J Dunkin1, J Martinez, P A Bejarano, C D Smith, K Chang, A S Livingstone, W S Melvin.   

Abstract

BACKGROUND: The goal of this study was to determine the optimal treatment parameters for the ablation of human esophageal epithelium using a balloon-based bipolar radiofrequency (RF) energy electrode.
METHODS: Immediately prior to esophagectomy, subjects underwent esophagoscopy and ablation of two separate, 3-cm long, circumferential segments of non-tumor-bearing esophageal epithelium using a balloon-based bipolar RF energy electrode (BARRX Medical, Inc., Sunnyvale, CA, USA). Subjects were randomized to one of three energy density groups: 8, 10, or 12 J/cm2. RF energy was applied one time (1x) proximally and two times (2x) distally. Following resection, sections from each ablation zone were evaluated using H&E and diaphorase. Histological endpoints were complete epithelial ablation (yes/no), maximum ablation depth, and residual ablation thickness after tissue slough. Outcomes were compared according to energy density group and 1x vs 2x treatment.
RESULTS: Thirteen male subjects (age, 49-85 years) with esophageal adenocarcinoma underwent the ablation procedure followed by total esophagectomy. Complete epithelial removal occurred in the following zones: 10 J/cm2 (2x) and 12 J/cm2 (1x and 2x). The maximum depth of injury was the muscularis mucosae: 10 and 12 J/cm2 (both 2x). A second treatment (2x) did not significantly increase the depth of injury. Maximum thickness of residual ablation after tissue slough was only 35 microm.
CONCLUSIONS: Complete removal of the esophageal epithelium without injury to the submucosa or muscularis propria is possible using this balloon-based RF electrode at 10 J/cm2 (2x) or 12 J/cm2 (1x or 2x). A second application (2x) does not significantly increase ablation depth. These data have been used to select the appropriate settings for treating intestinal metaplasia in trials currently under way.

Entities:  

Mesh:

Year:  2005        PMID: 16333533     DOI: 10.1007/s00464-005-8279-9

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   3.453


  9 in total

1.  Ablation treatment for Barrett oesophagus: what depth of tissue destruction is needed?

Authors:  R Ackroyd; N J Brown; T J Stephenson; C J Stoddard; M W Reed
Journal:  J Clin Pathol       Date:  1999-07       Impact factor: 3.411

Review 2.  Clinical practice. Barrett's Esophagus.

Authors:  Stuart Jon Spechler
Journal:  N Engl J Med       Date:  2002-03-14       Impact factor: 91.245

3.  Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus.

Authors:  Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

Review 4.  Ablation therapy for Barrett's esophagus.

Authors:  Glenn M Eisen
Journal:  Gastrointest Endosc       Date:  2003-11       Impact factor: 9.427

5.  Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus.

Authors:  Robert A Ganz; David S Utley; Roger A Stern; Jerome Jackson; Kenneth P Batts; Paul Termin
Journal:  Gastrointest Endosc       Date:  2004-12       Impact factor: 9.427

Review 6.  Barrett's esophagus and esophageal adenocarcinoma.

Authors:  B J Reid
Journal:  Gastroenterol Clin North Am       Date:  1991-12       Impact factor: 3.806

7.  Prevalence of Barrett's esophagus in asymptomatic individuals.

Authors:  Lauren B Gerson; Katerina Shetler; George Triadafilopoulos
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

8.  Screening for Barrett's esophagus in colonoscopy patients with and without heartburn.

Authors:  Douglas K Rex; Oscar W Cummings; Michael Shaw; Mark D Cumings; Roy K H Wong; Raj S Vasudeva; Donal Dunne; Emad Y Rahmani; Debra J Helper
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

9.  Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.

Authors:  S J Winawer; A G Zauber; M N Ho; M J O'Brien; L S Gottlieb; S S Sternberg; J D Waye; M Schapiro; J H Bond; J F Panish
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

  9 in total
  34 in total

Review 1.  Barrett's esophagus with high-grade dysplasia: focus on current treatment options.

Authors:  Leonidas Lekakos; Nikolaos P Karidis; Dimitrios Dimitroulis; Christos Tsigris; Gregory Kouraklis; Nikolaos Nikiteas
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

Review 2.  Endoscopic management of Barrett's esophagus: advances in endoscopic techniques.

Authors:  Ali Azarm; Ismet Lukolic; Meenal Shukla; Ronald Concha-Parra; Frank Gress
Journal:  Dig Dis Sci       Date:  2012-07-04       Impact factor: 3.199

3.  Radiofrequency ablation of Barrett's esophagus: let's not get ahead of ourselves.

Authors:  Gary W Falk
Journal:  Dig Dis Sci       Date:  2010-07       Impact factor: 3.199

4.  Endoscopic water jets used to ablate Barrett's esophagus: preliminary results of a new technique.

Authors:  M Kroh; R Hall; S Udomsawaengsup; A Smith; L Yerian; B Chand
Journal:  Surg Endosc       Date:  2008-03-06       Impact factor: 4.584

Review 5.  Advanced endoscopic technologies.

Authors:  Kevin M Reavis; W Scott Melvin
Journal:  Surg Endosc       Date:  2008-04-10       Impact factor: 4.584

6.  Is it justified to ablate flat-type esophageal squamous cancer? An analysis of endoscopic submucosal dissection specimens of lesions meeting the selection criteria of radiofrequency studies.

Authors:  Marnix Jansen; Dirk W Schölvinck; Ryoji Kushima; Shigeki Sekine; Bas L A M Weusten; Guiqi Q Wang; David E Fleischer; Shigetaka Yoshinaga; Sanford M Dawsey; Sybren L Meijer; Jacques J G H M Bergman; Ichiro Oda
Journal:  Gastrointest Endosc       Date:  2014-12       Impact factor: 9.427

7.  Effective treatment of chronic radiation proctitis using radiofrequency ablation.

Authors:  Chao Zhou; Desmond C Adler; Laren Becker; Yu Chen; Tsung-Han Tsai; Marisa Figueiredo; Joseph M Schmitt; James G Fujimoto; Hiroshi Mashimo
Journal:  Therap Adv Gastroenterol       Date:  2009-01-01       Impact factor: 4.409

Review 8.  History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.

Authors:  Stuart Jon Spechler; Rebecca C Fitzgerald; Ganapathy A Prasad; Kenneth K Wang
Journal:  Gastroenterology       Date:  2010-01-18       Impact factor: 22.682

9.  Predictors for postoperative esophageal stricture after balloon-based radiofrequency ablation for early esophageal squamous neoplasia: a multicenter validation study.

Authors:  Wen-Lun Wang; I-Wei Chang; Chien-Chuan Chen; Wei-Lun Chang; Yin-Yi Chu; Ping-Hsiu Wu; Wei-Chen Tai; Po-Yueh Chen; Ping-Hsin Hsieh; Chen-Shuan Chung; Chi-Yang Chang; Jaw-Town Lin; Hsiu-Po Wang; Ching-Tai Lee
Journal:  Therap Adv Gastroenterol       Date:  2016-02-25       Impact factor: 4.409

10.  Treatment of ultralong-segment Barrett's using focal and balloon-based radiofrequency ablation.

Authors:  Melina C Vassiliou; Daniel von Renteln; Daniel C Wiener; Stuart R Gordon; Richard I Rothstein
Journal:  Surg Endosc       Date:  2009-08-27       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.